Beverly Biller is an Endocrinology/Metabolic physician affiliated with Harvard University. OpenAlex indexes 498 publications with 24,631 citations (h-index 78); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Zero Emerson Place
Neuroendocrine Suite 112eo 112
Boston, MA 02114
Telephone
617-726-7948Registry record last updated 1 Sept 2009.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year202510 payments$18,365openpaymentsdata.cms.gov ↗
- Novo Nordisk Health Care AGProgram year20257 payments$15,003openpaymentsdata.cms.gov ↗
- RECORDATI_RARE_DISEASES_INC.Program year20256 payments$11,444openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
50.6%l-Thyroxine26.4%Levothyroxine Sodium100%Part D≥12 patientsRecombinant Human Growth Hormone24.1%Genotropin100%Part D<11 patientsMetabolism & gastrointestinal
27.6%Corticosteroid27.6%Prednisone100%Part D<11 patientsGenitourinary & hormones
21.8%Androgen21.8%Testosterone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1989–1999 per NIH RePORTER. The latest:
- PHYSIOLOGIC EFFECTS OF LONG TERM GROWTH HORMONE IN ACQUIRED GH DEFICIENCY
Massachusetts General Hospital
FY1999M01RR001066 - PHYSIOLOGIC EFFECTS OF LONG TERM GROWTH HORMONE IN ACQUIRED GH DEFICIENCY
Massachusetts General Hospital
FY1998M01RR001066 - PHYSIOLOGIC EFFECTS OF LONG TERM GROWTH HORMONE IN GH DEFICIENCY.
Massachusetts General Hospital
FY1997M01RR001066
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement
Nature Reviews Endocrinology
2023 - Multidisciplinary management of acromegaly: A consensus
Reviews in Endocrine and Metabolic Disorders
2020 - A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
The Journal of Clinical Endocrinology & Metabolism
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Benjamin Ebert, MD
Harvard University
Mark Shrime, MD
Harvard University
Thoralf Sundt, MD
Harvard University
Dhaval Kolte, MBBS, PhD
Harvard University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”